Literature DB >> 11587227

P53 downregulation in myelodysplastic syndrome--a quantitative analysis by competitive RT-PCR.

G Totzke, T Brüning, H Vetter, K Schulze-Osthoff, Y Ko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11587227     DOI： 10.1038/sj.leu.2402233

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  Clinical Relevance of p53 Immunohistochemical Stain in the Differential Diagnosis Between Pediatric Aplastic Anemia and Refractory Cytopenia of Childhood.

Authors:  Sang Hyuk Park; Hyun-Sook Chi; Young-Uk Cho; Seongsoo Jang; Chan-Jeoung Park; Ho-Joon Im; Jong-Jin Seo
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

2.  CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.

Authors:  Choong-Hwan Cha; Chan-Jeoung Park; Hyun-Sook Chi; Eul Ju Seo; Seongsoo Jang; Young-Uk Cho; Kyoo-Hyung Lee; Je-Hwan Lee; Jung-Hee Lee; Ho Joon Im; Jong-Jin Seo
Journal:  Ann Lab Med       Date:  2014-10-28       Impact factor: 3.464
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.